Business Standard

Here's why Mehul Kothari recommends buying Metropolis, Thyrocare Tech

According to the technical analyst from Anand Rathi, Metropolis Healthcare can rally to Rs 1,800, while Thyrocare Technologies can rise up to Rs 740.

Web Exclusive Premium


Mehul Kothari Mumbai
Buy Near: Rs 1,500
Target: Rs 1,800
Stop Loss: Rs 1,350

Like other diagnostic stocks, even Metropolis Healthcare was under corrective mode since many months. In recent sessions, the stock has confirmed a higher top formation on the daily scale.

Also, we are witnessing a falling wedge breakout on the daily scale. Thus, we advise traders to buy the stock near Rs 1,500 for a target of Rs 1,800 in the coming sessions.

Buy Near: Rs 680
Target: Rs 740
Stop Loss: Rs 650

Even Thyrocare Technologies was under a heavy corrective mode and now has confirmed higher top and higher bottom formation on the daily scale.

At this

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 27 2022 | 7:35 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to